Syngen Biotech Co

Syngen Biotech Co FCF per Share

The Free Cash Flow per Share of Syngen Biotech Co (8279.TWO) as of Nov 4, 2026 is 8.97 TWD. In the previous year, Free Cash Flow per Share was 10.47 TWD — a change of -14.32% (lower).

FCF per Share

8.97TWD

YoY

-14.32%

Last updated:

Free Cash Flow per Share of Syngen Biotech Co is 2025 8.97 TWD. Free Cash Flow per Share of Syngen Biotech Co was 2024 10.47 TWD. It decreases by -14.32% lower compared to the previous year.

The Syngen Biotech Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2017
-1.49 TWD
Jan 1, 2018
0.08 TWD
Jan 1, 2019
7.82 TWD
Jan 1, 2021
10.14 TWD
Jan 1, 2022
-11.34 TWD
Jan 1, 2023
11.86 TWD
Jan 1, 2024
10.47 TWD
Jan 1, 2025
8.97 TWD
The Syngen Biotech Co FCF per Share history
YEARFCF per ShareYoY
8.97TWD-14.32%
10.47TWD-11.71%
11.86TWD-204.59%
-11.34TWD-211.79%
10.14TWD+29.65%
7.82TWD+9,148.66%
0.08TWD-105.69%
-1.49TWD-217.73%
1.26TWD-45.92%
2.33TWD-317.19%
-1.07TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Syngen Biotech Co Stock analysis

What does Syngen Biotech Co do? Syngen Biotech Co., Ltd. generates revenue through the manufacture and sale of microbial pharmaceuticals and biochemical nutrition products. The company's portfolio includes active pharmaceutical ingredients, health food raw materials, and animal health products. Additionally, the firm offers medical equipment such as bone density analyzers, blood glucose analyzers, and biochemical analyzers to its customer base. Syngen Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngen Biotech Co stock

Free Cash Flow per Share of Syngen Biotech Co is 8.97 TWD in 2025.

Free Cash Flow per Share of Syngen Biotech Co changed from 10.47 TWD to 8.97 TWD, representing a -14.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Syngen Biotech Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Syngen Biotech Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Syngen Biotech Co